Sustainable antimicrobial surveillance programs essential for controlling neisseria gonorrhoeae superbug

Sexually Transmitted Diseases

Volumn 38, Issue 10, 2011, Pages 899-901

  Dillon, Jo Anne R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; KANAMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE; THIAMPHENICOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANADA; DRUG EFFICACY; DRUG TREATMENT FAILURE; GONORRHEA; HUMAN; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; REVIEW;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE;

EID: 80052962104     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318232459b     Document Type: Review

References (25)

1. Lewis DA. The gonococcus fights back: Is this time a knock out? Sex Transm Infect 2010; 86:415-421.
2. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Therap 2009; 7:821-834.
3. Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009; 58:683-687.
4. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010; 15:pii-19721.
5. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011; 16:pii-19792.
6. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: Time for a pharmacodynamic rethink? J Antimicrob Chemother 2010; 65:2141-2148.
7. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55:3538-3545.
8. Dillon JA, Pauzé M. Introductory address: Resistance to antimicrobial agnts-What next for Neisseria gonorrhoeae? Sex Transm Dis 1984; 11:353-359. (Pubitemid 15188104)
9. Sparling PF. Antibiotic resistance in Neisseria gonorrhoeae. Med Clin N Am 1972; 56:1133-1144.
10. World Health Organization. Global surveillance network for gonococcal antimicrobial susceptibility. WHO document 1990; WHO/VDT/90.452.
11. WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2009. Commun Dis Intell 2011; 35:2-7.
12. Center for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2006 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report-2006. CDC 2008; Atlanta, GA, USA.
13. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010; 86:427-432.
14. Martin I, Jayaraman G, Wong T, et al.; on Behalf of the Canadian Public Health Laboratory Network. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Sex Transm Dis 2011; 38:892-898.
15. Dillon JR, Eidus L, Diena BB. Cross-Canada survey of susceptibility of Neisseria gonorrhoeae isolates to six antimicrobial agents. Can Med Assoc J 1978; 119:223-228. (Pubitemid 9005177)
16. Dillon JR. National microbiological surveillance of the susceptibility of gonococcal isolates to antimicrobial agents. Can J Infect Dis 1992; 3:202-204.
17. Dillon JR, Ruben M, Li H, et al. Challenges in the control of gonorrhea in South America and the Caribbean: Monitoring the development of resistance to antibiotics. Sex Transm Dis 2006; 33:87-95.
18. Starnino S, Liao M, Ruben M, Storey A, Dillon JAR, GASP-LAC Network. Neisseria gonorrhoeae antimicrobial susceptibility in Latin America and the Caribbean (2000-2009)-A contribution to the treatment guidelines revision. Abstract P1-S1.45. 19th Biennial Conference of the International Society for Sexually Transmitted Diseases Research (ISSTDR), July 10-13, 2011, Quebec City, Canada. Sex Trans Infect 2011; 87(Suppl 1):A117.
19. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148:606-613. (Pubitemid 351669134)
20. World Health Organization (WHO). Consultation on the strategic response to the threat of untreatable Neisseria gonorrhoeae and emergence of cephalosporin resistance in Neisseria gonorrhoeae. 7-9 April 2010, Manila, Philipines. WHO Meeting Report 2010. (WP)HIS/2010/CDC.
21. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: An ongoing challenge. J Mol Diagn 2006; 8:3-15. (Pubitemid 43257429)
22. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections. 2010. Available at: http://www.phacaspc. gc.ca/std-mts/sti-its/guide-lingnesdir-eng.php (accessed November 2010).
23. Thakur SD, Nagle E, Levett P, et al. Isolates of Neisseria gonorrhoeae from Saskatchewan are susceptible to most antibiotics except tetracycline. AMMI Canada-CACMID Annual Conference, May 6-8, 2010. Edmonton, Canada. Abstract SP 25. Can J Infect Dis Med Microbiol 2010; 21(Suppl A):38A.
24. Chisholm SA, Quaye N, Cole MJ, et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother 2011; 66:592-595.
25. Furuya R, Nakayama H, Kanayama A, et al. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother 2006; 12:172-176. (Pubitemid 44327183)